Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NovaBay Pharmaceuticals (NBY) Preferred Dividend Payments (2024)

Historic Preferred Dividend Payments for NovaBay Pharmaceuticals (NBY) over the last 1 years, with Q3 2024 value amounting to $1.0 million.

  • NovaBay Pharmaceuticals' Preferred Dividend Payments changed N/A to $1.0 million in Q3 2024 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, NovaBay Pharmaceuticals' Preferred Dividend Payments is $1.0 million.
  • Over the past 5 years, NovaBay Pharmaceuticals' Preferred Dividend Payments peaked at $1.0 million during Q3 2024, and registered a low of $1.0 million during Q3 2024.